Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kana Tsuneyoshi"'
Autor:
Hisatsugu Miyata, Izuru Nakamura, Didier Meulien, Yoshiyuki Murai, Masayoshi Takahashi, Kana Tsuneyoshi, Susumu Higuchi
Publikováno v:
Psychiatry and Clinical Neurosciences
Aim The safety and efficacy of nalmefene in Japanese patients with high or very high World Health Organization drinking risk level of alcohol dependence were assessed in a multicenter, randomized, double-blind, placebo-controlled, phase 3 (lead-in) s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0622115dc4f67d5f79af61e581a22bec
https://doi.org/10.1111/pcn.13017
https://doi.org/10.1111/pcn.13017
Autor:
Per Sørensen, Takako Hayashi, Hisatsugu Miyata, Didier Meulien, Yoshiyuki Murai, Kana Tsuneyoshi, Susumu Higuchi, Masayoshi Takahashi
Publikováno v:
Psychiatry and Clinical Neurosciences
AIMS Reducing alcohol consumption is one treatment approach for alcohol-dependent patients. This study compared nalmefene 20 mg and 10 mg with placebo, combined with psychosocial support, in alcohol-dependent Japanese patients with a high or very hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::919b535e5fc508ec0a129bbff5816b93
https://pubmed.ncbi.nlm.nih.gov/31298784
https://pubmed.ncbi.nlm.nih.gov/31298784
Publikováno v:
Brain and Behavior
Background Major depressive disorder (MDD) with concurrent anxiety symptoms may signal a difficult-to-treat patient. Brexpiprazole is a serotonin–dopamine activity modulator: a partial agonist at 5-HT1A and dopamine D2 receptors at similar potency,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::347fc6fab7f6bd1b75b9c46394749d89
http://europepmc.org/articles/PMC5064333
http://europepmc.org/articles/PMC5064333
Autor:
Ai Ota, Kana Tsuneyoshi, Pamela Perry, David V. Sheehan, Ross A. Baker, Richard H. Weisler, Emmanuelle Weiller
Publikováno v:
Journal of affective disorders. 204
BackgroundMajor depressive disorder (MDD) is a common, debilitating disorder with substantial socioeconomic burden. Many patients with MDD experience symptoms that impair functioning and productivity, often negatively affecting work or educational pu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c27a516e0f1f34d9e9fbf215b2d32e3d
https://pubmed.ncbi.nlm.nih.gov/27322768
https://pubmed.ncbi.nlm.nih.gov/27322768
Publikováno v:
International Journal of Neuropsychopharmacology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5c1b58f441772b5b6f3f028ee8a5c79
https://doi.org/10.1093/ijnp/pyw043.151
https://doi.org/10.1093/ijnp/pyw043.151
Autor:
Emmanuelle Weiller, Kana Tsuneyoshi, Catherine Weiss, Aleksandar Skuban, Y. Matsushima, Ross A. Baker
Publikováno v:
European Neuropsychopharmacology. 26:S406
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3847b88325500f50f71061502dade538
https://doi.org/10.1016/s0924-977x(16)31369-4
https://doi.org/10.1016/s0924-977x(16)31369-4
Autor:
A. Ota, Pamela Perry, Emmanuelle Weiller, Ross A. Baker, Richard H. Weisler, David V. Sheehan, Kana Tsuneyoshi
Publikováno v:
European Neuropsychopharmacology. 25:S449
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::064efabda0fbc8346f128c06ff090121
https://doi.org/10.1016/s0924-977x(15)30604-0
https://doi.org/10.1016/s0924-977x(15)30604-0